Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities
Pharmaceutics · 03.11.2023 · 15 (11) · 2579
DOI: 10.3390/pharmaceutics15112579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 03.11.2023. Verfasst von Jean Dinh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Certara UK Limited, Sheffield S1 2BJ, UK. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Physiologically based pharmacokinetic (PBPK) modeling is an approach to predicting drug pharmacokinetics, using knowledge of the human physiology involved and drug physiochemical properties. This approach is useful when predicting drug pharmacokinetics in under-studied populations, such as pediatrics. PBPK modeling is a particularly important tool for dose optimization for the neonatal population, given that clinical trials rarely include this patient population. However, important knowledge gaps exist for neonates, resulting in uncertainty with the model predictions. This review aims to outline the sources of variability that should be considered with developing a neonatal PBPK model, the data that are currently available for the neonatal ontogeny, and lastly to highlight the data gaps where further research would be needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Certara UK Limited, Sheffield S1 2BJ, UK.
- Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20903, USA.
- Pediatric Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
ORCID-Profile: Manuela Grimstein, Tamorah Lewis
Zitieren
APA
Dinh, J., Johnson, T. N., Grimstein, M., & Lewis, T. (2023). Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities. Pharmaceutics, 15(11), 2579. https://doi.org/10.3390/pharmaceutics15112579
Vancouver
Dinh J, Johnson TN, Grimstein M, Lewis T. Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities. Pharmaceutics. 2023;15(11):2579. doi:10.3390/pharmaceutics15112579
BibTeX
@article{Dinh2023,
author = {Dinh, Jean and Johnson, Trevor N and Grimstein, Manuela and Lewis, Tamorah},
title = {Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {11},
pages = {2579},
doi = {10.3390/pharmaceutics15112579}
}
EUVIMED